URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Michelle Janelsins

Concepts (112)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Breast Neoplasms
6
2010
660
1.400
Why?
Antineoplastic Agents
5
2009
598
1.270
Why?
Cognition Disorders
2
2011
262
1.190
Why?
Neoplasms
7
2009
701
1.170
Why?
Tai Ji
3
2010
21
0.970
Why?
Survivors
5
2009
112
0.830
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2011
409
0.720
Why?
Dentate Gyrus
1
2010
24
0.710
Why?
Blood-Brain Barrier
1
2010
103
0.660
Why?
Insulin-Like Growth Factor I
1
2010
98
0.660
Why?
Gene Expression Regulation, Neoplastic
1
2011
247
0.640
Why?
Alzheimer Disease
2
2008
252
0.620
Why?
Insulin
1
2011
626
0.600
Why?
Cytokines
1
2011
555
0.570
Why?
Neurons
2
2008
1053
0.470
Why?
Inflammation
1
2008
518
0.470
Why?
Tumor Necrosis Factor-alpha
1
2008
627
0.460
Why?
Exercise
2
2009
155
0.330
Why?
Quality of Life
3
2009
486
0.310
Why?
Humans
16
2008
35000
0.290
Why?
Female
11
2009
19061
0.270
Why?
Aged
7
2009
6986
0.260
Why?
Middle Aged
8
2009
9461
0.250
Why?
Geriatric Assessment
2
2011
158
0.210
Why?
Boronic Acids
1
2012
25
0.200
Why?
Antibodies, Monoclonal, Humanized
1
2012
89
0.200
Why?
Pyrazines
1
2012
29
0.200
Why?
Multiple Myeloma
1
2012
73
0.190
Why?
Adult
5
2010
10906
0.190
Why?
Double-Blind Method
2
2010
985
0.190
Why?
Brain
2
2008
1161
0.190
Why?
Antineoplastic Agents, Hormonal
1
2011
44
0.180
Why?
National Institutes of Health (U.S.)
1
2011
60
0.180
Why?
Benzhydryl Compounds
1
2010
13
0.180
Why?
Interleukin-8
1
2011
108
0.180
Why?
Bone Density Conservation Agents
1
2011
45
0.180
Why?
Resistance Training
1
2010
6
0.180
Why?
tau Proteins
2
2008
94
0.180
Why?
Bromodeoxyuridine
1
2010
63
0.180
Why?
Vitamin D
1
2011
64
0.180
Why?
Chemokine CCL2
1
2011
124
0.170
Why?
Neurogenesis
1
2010
25
0.170
Why?
Radiation Injuries
1
2011
123
0.170
Why?
Central Nervous System Stimulants
1
2010
40
0.170
Why?
Weight Loss
1
2010
63
0.170
Why?
Aged, 80 and over
3
2010
2423
0.170
Why?
Fluorouracil
1
2010
77
0.170
Why?
Paclitaxel
1
2010
56
0.170
Why?
Cyclophosphamide
1
2010
169
0.170
Why?
Doxorubicin
1
2010
102
0.170
Why?
Mice
3
2008
5900
0.170
Why?
Pilot Projects
1
2011
426
0.170
Why?
Tumor Markers, Biological
1
2011
221
0.170
Why?
Medicare
1
2011
126
0.170
Why?
Plaque, Amyloid
1
2009
3
0.160
Why?
Mice, Transgenic
2
2008
735
0.160
Why?
Sleep Initiation and Maintenance Disorders
1
2009
45
0.160
Why?
Tauopathies
1
2009
5
0.160
Why?
Biomedical Research
1
2011
132
0.160
Why?
Fatigue
1
2010
122
0.160
Why?
Interleukin-6
1
2011
314
0.160
Why?
Analysis of Variance
1
2011
705
0.160
Why?
Transgenes
1
2008
69
0.160
Why?
Brain Neoplasms
1
2011
254
0.150
Why?
Amyloid beta-Peptides
1
2008
49
0.150
Why?
Dependovirus
1
2008
56
0.150
Why?
Myelin Sheath
1
2009
80
0.150
Why?
Microglia
1
2008
76
0.150
Why?
Mice, Inbred C57BL
2
2009
1613
0.150
Why?
Smoking
1
2011
387
0.150
Why?
Bone and Bones
1
2010
330
0.140
Why?
Cell Proliferation
1
2010
480
0.140
Why?
Genetic Vectors
1
2008
328
0.140
Why?
Macrophages
1
2008
329
0.140
Why?
Male
7
2009
18870
0.130
Why?
Prostatic Neoplasms
1
2011
548
0.130
Why?
Aging
1
2011
692
0.120
Why?
Risk Factors
1
2011
2172
0.120
Why?
Animals
3
2008
15647
0.120
Why?
Time Factors
1
2011
3047
0.110
Why?
Age Factors
3
2009
1060
0.100
Why?
Osteoporosis
2
2010
86
0.080
Why?
Prevalence
2
2009
530
0.080
Why?
United States
2
2011
2511
0.050
Why?
Nutrition Disorders
1
2011
17
0.050
Why?
Organizational Innovation
1
2011
27
0.050
Why?
Hearing Disorders
1
2011
23
0.050
Why?
Vitamin D Deficiency
1
2011
31
0.050
Why?
Urinary Incontinence
1
2011
47
0.050
Why?
Accidental Falls
1
2011
47
0.050
Why?
Memory Disorders
1
2011
42
0.050
Why?
Syndrome
1
2011
203
0.050
Why?
Neoplasm Staging
1
2011
326
0.040
Why?
Vision Disorders
1
2011
72
0.040
Why?
Bone Density
1
2011
103
0.040
Why?
Collagen Type I
1
2010
46
0.040
Why?
Placebos
1
2010
177
0.040
Why?
Feasibility Studies
1
2010
189
0.040
Why?
Comorbidity
1
2011
365
0.040
Why?
Health Status
1
2011
263
0.040
Why?
Survival Rate
1
2011
584
0.040
Why?
Nerve Fibers, Myelinated
1
2009
36
0.040
Why?
Continental Population Groups
1
2009
116
0.040
Why?
Logistic Models
1
2011
581
0.040
Why?
Prognosis
1
2011
1030
0.040
Why?
Bone Resorption
1
2010
227
0.040
Why?
Peptides
1
2010
277
0.040
Why?
Sex Factors
1
2009
561
0.040
Why?
Biological Markers
1
2010
532
0.040
Why?
Depression
1
2011
419
0.030
Why?
Retrospective Studies
1
2011
2167
0.030
Why?
Adolescent
1
2010
4513
0.020
Why?

Visualizations


Janelsins's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department